Assays

Simultaneously test for the most
common & treatable STIs

The BD MAX™ CT/GC and CT/GC/TV assays* provide results for two or three of the most prevalent non-viral sexually transmitted infections from just one specimen, collection, and run

Chlamydia trachomatis (CT)
Neisseria gonorrhoeae (GC)
Trichomonas vaginalis (TV)
  • The versatility to test for CT/GC or CT/GC/TV from a single specimen collection based on patient risk
  • High sensitivity and specificity for accurate and reliable results – enhancing quality patient care and supporting clinical decision making
  • Fully integrated on the BD MAX™ System with ready to use reagents stored at room temperature and a fully automated platform to free up staff for other tasks; currently being developed for the BD COR™ System*

The BD MAX™ CT/GC and CT/GC/TV assays* provide high sensitivity and specificity

  • Accurate and actionable results for asymptomatic and symptomatic individuals1
  • Dual targets for detection of Chlamydia and Gonorrhoeae**
The burden of STIs
The consequences of CT, GC, and TV can be serious. Long- term sequelae include pelvic inflammatory disease, ectopic pregnancy, infertility, and pre-term or low birth-weight infants.
More than 1 million STIs are acquired every day. In 2016, WHO estimated 376 million new infections with 1 of 4 STIs: trichomoniasis (156 M), chlamydia (127 M), gonorrhoea (87 M) and syphilis (6.3 M).2
Despite being the most common curable STI worldwide, trichomoniasis is not a reportable disease in Europe, and is often not a requested test.
Challenges associated with screening and diagnosis of STIs
Hospitals and laboratories are faced with increasing challenges in managing workload and patient needs.
Screening and/or diagnosis of STIs requires an assay capable of accurate detection of infections that are often asymptomatic, while common symptoms can make differentiating these infections difficult.
Labs and clinicians require results they can trust and efficient solutions that help them reduce labour, workload and costs.

The BD MAX™ CT/GC and CT/GC/TV assays* are fully integrated
on the BD MAX™ System

Discover BD’s full Sexually Transmitted Infections Portfolio

*The BD COR System & all related assays are currently under development, not available for sale yet.  

**coming soon

CT, Chlamydia trachomatis; GC, Neisseria gonorrhoeae; M, Million; STI, Sexually Transmitted Infection; TV, Trichomonas vaginalis; WHO, World Health Organization.

1. Package Insert, BD MAX CT/GC and BD MAX CT/GC/TV Assay. 2. Sexually transmitted infections (STIs). Factsheet. June 14, 2019. Available at: https://www.who.int/en/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis). Accessed February 2020.